Technical mission: HIV in Cyprus, 15–17 October
The number of new HIV cases diagnosed annually in Cyprus has been on the rise since 2005: more than 50 new cases of HIV were diagnosed every year from 2011 to 2013. This report addresses this issue and provides options on how Cyprus can respond to the epidemic.
Travellers' health and infectious diseases on aircraft
As increasing numbers of people travel by air, the potential risk of introduction and spread of infectious diseases by travellers is on the rise. Figures from Eurostat reveal that around 900 million passengers annually are carried on flights within the European Union (EU) alone.
Protocols for cohort database studies to measure influenza vaccine effectiveness in the EU and EEA Member States
Mission Report, Tuberculosis in Latvia, 22 – 26 October 2012
Mission report: Assessment of Latvia’s reference microbiology laboratory system
The Latvian Centre for Disease Prevention and Control – on behalf of the Ministry of Health of the Republic of Latvia – requested the European Centre for Disease Prevention and Control to evaluate the current national reference laboratory (NRL) system.
Managing heterogeneity when pooling data from different surveillance systems
This report addresses the heterogeneity that arises from pooling data from different surveillance systems and provides statistical and procedural approaches to minimise or remove its impact. The aim is to support public health specialists and researchers in answering key research and policy questions using available European data to the fullest possible extent.
European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.